| Trial ID: | L2867 |
| Source ID: | NCT00933972
|
| Associated Drug: |
Ro4998452
|
| Title: |
A Study of RO4998452 in Type 2 Diabetes Patients With Varying Degrees of Renal Impairment
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus Type 2
|
| Interventions: |
DRUG: RO4998452
|
| Outcome Measures: |
Primary: Creatinine clearance; Pk parameters; adverse events, Days 1-3 | Secondary: Blood glucose; meal tolerance test, Days 1-3
|
| Sponsor/Collaborators: |
Sponsor: Hoffmann-La Roche
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
36
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2009-06
|
| Completion Date: |
2010-09
|
| Results First Posted: |
|
| Last Update Posted: |
2016-11-02
|
| Locations: |
Renton, Washington, 98055, United States|Moscow, 115419, Russian Federation
|
| URL: |
https://clinicaltrials.gov/show/NCT00933972
|
